ARCHIVES

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

This article is from The Cancer Letter archive.

Vol. 17 No. 01 | January 4, 1991

Download PDF Visit The Full Archive

Related Articles

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

Duke Comprehensive Cancer Center Wins Core Grant Renewal

September 17, 2010

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

New Journal Examines Claims Of Proponents Of Alternative Medicine

October 24, 1997

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006

Congress Agrees On $1.989 Bil. FY92 NCI Budget, But Most Of Increase Not Available Till 1993

November 8, 1991